SHIRLEY, NY – Jul 23, 2019 – Creative Biolabs, one of the world-leading suppliers and manufacturers from the USA, has recently launched its fully-developed soluble single-chain T-cell receptor (scTCR) products to researchers. The products ranges also include therapeutic antibody and therapeutic protein products, based on the most powerful platforms and techniques in this field with unrivaled accuracy and sensitivity.
Therapeutic antibody, particularly monoclonal antibody, can activate, inhibit or alter the endogenous immune response to specific cells or molecules. Antibody-based drugs are revolutionizing the treatment of cancer, inflammation and autoimmune diseases as well as many other types of diseases. From custom biological reagents to antibody drug development, Creative Biolabs offers a comprehensive range of services to help in basic and translational biomedical research and pharmaceutical research & development.
Therapeutic protein drugs are an important class of drugs that provide services to patients who need novel therapies. Creative Biolabs is a pioneer in the discovery and manufacture of recombinant and therapeutic antibodies, providing the most comprehensive list of antibody products in the world. Recently approved recombinant protein therapeutics have been developed to treat a variety of clinical indications including cancer, autoimmunity/inflammation, exposure to infectious agents and genetic diseases.
“With years of experience in developing immunological reagents, Creative Biolabs is one of the largest suppliers of soluble single-chain T-cell receptor (scTCR) products. We own the most comprehensive list of various scTCR products. Our scientists are pleased to provide high-quality soluble TCR to help our customers worldwide,” stated by Creative Biolabs’ executive vice president.
Compared to the full-length TCRs, why are the single-chain TCRs widely used?
• High expression and stable protein
• Fast purification
• High yields
• Improved tissue penetration
• Minimal size
“scTCR can be used for the treatment of cancer, viral diseases, autoimmune diseases, etc. Creative Biolabs scientists are committed to discovering and developing new single-chain TCR products that may represent a new set of immunotherapeutics that may have the potential to expand the range of tumors available for targeted therapies beyond those currently addressed by conventional antibody-based approaches. We offer soluble TCR custom services and high-quality scTCR products to meet customer needs,” said Dr. Johnson.
About Creative Biolabs:
With years of experience in providing one-stop pre-clinical development services, Creative Biolabs has built a team of experts with solid knowledge regarding gene therapy who are fully competent in assisting global clients. Services include but are unlimited to delivery vehicle development, potency tests, safety and toxicology analysis, solutions of specific gene therapy development for diseases, etc.
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Address:45-1 Ramsey Road
State: New York
Country: United States